Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration

Archives of Ophthalmology

Volumn 115, Issue 6, 1997, Pages 741-747

  Maguire, Maureen G ^a   Bressler, Susan B ^b   Bresskr, Neil M ^c   Alexander, Judith ^a   Hiner, Cheryl J ^b   Javomik, Noreen B ^c   Phillips, Deborah ^a   Marsh, Martaj ^b   Haivfeins, Barbara S ^c   Burgess, Dean B ^a   Chandra, Suresh ^a   Klein, Michael L ^b   David, H ^a   Stevens, Thomas ^c   Fine, Stuart L ^a   Hawhins, Barbara S ^c  

^a Macular Photocoagulation Study Group   (United States)

^b Maadar Photocoagidation Study (MPS)   (United States)

^c Wilmer Clinical Trials and Biometry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; LASER COAGULATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION;

EID: 8544234955     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150743009     Document Type: Article

References (37)

1. Vingerling JR, Klaver CCW, Hofman A, de Jong PTVM. Epidemiology of agerelated maculopathy. Epidemiol Rev. 1995:17:347-360.
2. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study, II: association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977:106:33-41.
3. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol. 1979;11:1197-1201.
4. Delaney WV Jr, Dates RP. Senile macular degeneration: preliminary study. Ann Ophthalmol. 1982:14:21-24.
5. Hyman LG, Lilienfeld AM, Ferris FL, Fine SL Senile macular degeneration: a case-control study. Am J Epidemiol. 1983:118:213-227.
6. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham study. Arch Ophthalmol. 1986:104:216-219.
7. Newsome DA, Swartz M, Leone NC, Elson RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988:106:192-198.
8. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with age-related macular degeneration: an analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128' 700-710. .
9. Klein R, Klein BEK, Linton KLP, DeMets DL. The Beaver Dam Eye Study: the relationship of age-related maculopathy to smoking. Am J Epidemiol. 1993; 137:190-200.
10. Klein R, Klein BEK, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1993;100:406-414.
11. Gass JDM. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973:90:206-217.
12. Teeters VW, Bird AC. The development of neovascularization in senile disciform macular degeneration. Am J Ophthalmol. 1973:76:1-18.
13. Chandra SR, Gragoudas ES, Friedman E, Van Buskirk EM, Klein ML. Natural history of disciform degeneration of the macula. Am J Ophtha/mol. 1974;78: 579-582.
14. Gregor Z, Bird AC, Chisholm IH. Senile disciform macular degeneration in the second eye. Br J Ophthalmol. 1977:61:141-147.
15. Gregor Z, Joffe L Senile macular changes in the black African. BrJ Ophthalmol. 1978:62:547-550.
16. Strahlman ER, Rne SL, Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol. 1983:101:1191-1193.
17. Bressler SB, Maguire MG, Bressler NM, Fine SL, Macular Photocoagulation Study Group. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol. 1990:108:1442-1447.
18. Eye Disease Case-Control Study Group. Risk factors for neovascular agerelated macular degeneration. Arch Ophthalmol. 1992:110:1701-1708.
19. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993:111:104-109.
20. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: Eye Disease CaseControl Study Group. JAMA 1994:272:1413-1420.
21. Cruickshanks KJ, Klein R, Klein BEK. Sunlight and age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophtha/mol. 1993:111:514-518.
22. Holz FG, Wolfensberger TJ, Piguet B,. Bilateral macular drusen in age-related macular degeneration. Ophthalmology. 1994:101:1522-1528.
23. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1990:108:816-824.
24. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch Ophthalmol 1994;112:500-509.
25. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991:109:1220-1231.
26. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991:109:1232-1241.
27. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol. 1993:111:1200-1209.
28. Macular Photocoagulation Study Group. Macular Photocoagulation Study Manual of Procedures. Springfield, Va: National Technical Information Service; 1990. NTIS Accession No. PB90-115536.
29. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in agerelated macular degeneration: guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol. 1991;109:1242-1257.
30. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989;107:847-852.
31. Klein R, Davis MD, Magli YL, Segal P, Klein BEK, Hubbard L The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991:98:1128-1134.
32. International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995:39:367-374.
33. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JAm StatAssoc. 1958:53:457-481.
34. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966:50:163-170.
35. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;2:187-220.
36. Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol. 1993;111:1189-1199.
37. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1982;100:912-918.